Tudor Investment Corp ET AL Acquires New Shares in Simulations Plus, Inc. $SLP

Tudor Investment Corp ET AL purchased a new stake in Simulations Plus, Inc. (NASDAQ:SLP) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 120,101 shares of the technology company’s stock, valued at approximately $1,810,000. Tudor Investment Corp ET AL owned 0.60% of Simulations Plus as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Raymond James Financial Inc. acquired a new stake in shares of Simulations Plus during the second quarter worth $25,000. Quarry LP acquired a new position in Simulations Plus in the 3rd quarter worth $28,000. CWM LLC increased its holdings in Simulations Plus by 3,729.1% during the 3rd quarter. CWM LLC now owns 2,106 shares of the technology company’s stock worth $32,000 after purchasing an additional 2,051 shares in the last quarter. Farther Finance Advisors LLC bought a new position in Simulations Plus during the 3rd quarter worth about $40,000. Finally, US Bancorp DE increased its holdings in Simulations Plus by 32.5% during the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock worth $93,000 after purchasing an additional 1,513 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on SLP. Zacks Research lowered Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. TD Cowen reiterated a “hold” rating on shares of Simulations Plus in a report on Thursday, January 8th. Wall Street Zen raised Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, March 21st. Citigroup restated a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Finally, BTIG Research downgraded Simulations Plus from a “buy” rating to a “neutral” rating in a research report on Thursday, December 18th. Three equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Simulations Plus currently has an average rating of “Hold” and a consensus target price of $25.00.

Simulations Plus Price Performance

Shares of NASDAQ SLP opened at $11.42 on Friday. The stock has a market capitalization of $230.08 million, a price-to-earnings ratio of -3.57 and a beta of 1.17. The business has a 50-day moving average of $13.93 and a 200-day moving average of $16.16. Simulations Plus, Inc. has a fifty-two week low of $11.16 and a fifty-two week high of $36.45.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.05). Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.The company had revenue of $18.42 million for the quarter, compared to the consensus estimate of $18.05 million. During the same quarter in the previous year, the company posted $0.17 EPS. On average, sell-side analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.